Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
173.43
1.43 (0.83%)
At close: May 30, 2025, 3:59 PM
173.34
-0.05%
After-hours: May 30, 2025, 07:45 PM EDT
Quest Diagnostics Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2015 |
|---|---|---|---|---|
| Diagnostic Information Services Business Revenue | 9.61B | 8.98B | 9.61B | 6.96B |
| Diagnostic Information Services Business Revenue Growth | +7.11% | -6.59% | +37.96% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 476M | 466M | 448M | 406M | 436M | 402M | 380M | 416M | 439M | 563M | 464M | 422M | 425M | 464M | 427M | 429M | 407M | 447M | 396M | 360M | 347M | 349M | 362M | 362M | 384M | 356M | 354M | 351M | 363M | 453M | 423M | 437M | 437M | 400M | 409M | 430M | 442M | 429M | 402M | 429M | 419M |
| Selling, General, and Administrative Revenue Growth | +2.15% | +4.02% | +10.34% | -6.88% | +8.46% | +5.79% | -8.65% | -5.24% | -22.02% | +21.34% | +9.95% | -0.71% | -8.41% | +8.67% | -0.47% | +5.41% | -8.95% | +12.88% | +10.00% | +3.75% | -0.57% | -3.59% | 0.00% | -5.73% | +7.87% | +0.56% | +0.85% | -3.31% | -19.87% | +7.09% | -3.20% | 0.00% | +9.25% | -2.20% | -4.88% | -2.71% | +3.03% | +6.72% | -6.29% | +2.39% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |